Vanessa-Giselle Peschard, Rebecca Scherzer, Michelle M Estrella, Mark J Sarnak, Simon B Ascher, James Lash, Joseph V Bonventre, Jason H Greenberg, Orlando M Gutierrez, Jeffrey R Schelling, Ronit Katz, Katharine L Cheung, Emily B Levitan, Sarah J Schrauben, Mary Cushman, Titilayo O Ilori, Chirag R Parikh, Paul L Kimmel, Panduranga S Rao, Jonathan J Taliercio, James Sondheimer, Rachel Shulman, Steven G Coca, Jing Chen, Vasan S Ramachandran, Joachim H Ix, Michael G Shlipak
{"title":"Defining Kidney Health Dimensions and their Associations with Adverse Outcomes in Persons with Diabetes and Chronic Kidney Disease.","authors":"Vanessa-Giselle Peschard, Rebecca Scherzer, Michelle M Estrella, Mark J Sarnak, Simon B Ascher, James Lash, Joseph V Bonventre, Jason H Greenberg, Orlando M Gutierrez, Jeffrey R Schelling, Ronit Katz, Katharine L Cheung, Emily B Levitan, Sarah J Schrauben, Mary Cushman, Titilayo O Ilori, Chirag R Parikh, Paul L Kimmel, Panduranga S Rao, Jonathan J Taliercio, James Sondheimer, Rachel Shulman, Steven G Coca, Jing Chen, Vasan S Ramachandran, Joachim H Ix, Michael G Shlipak","doi":"10.2215/CJN.0000000676","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Individual kidney tubule biomarkers are associated with risks for chronic kidney disease (CKD) progression and mortality in persons with diabetes. Integrating multiple kidney biomarkers using a latent variable method of exploratory factor analysis could define distinct dimensions of kidney health, and their associations with adverse outcomes.</p><p><strong>Methods: </strong>We conducted a factor analysis of 17 candidate urine and plasma biomarkers in 1,256 participants with diabetes and estimated glomerular filtration rate (eGFR) <60ml/min/1.73 m2 from the Chronic Renal Insufficiency Cohort (CRIC; N=701) and the Reasons for Geographic and Racial Differences in Stroke (REGARDS; N=555) studies. We used Cox proportional hazards models to evaluate the associations of identified factors with CKD progression and mortality, adjusting for baseline clinical risk factors, eGFR and albuminuria.</p><p><strong>Results: </strong>Three factor scores comprising 10 biomarkers were identified: systemic inflammation and filtration (plasma tumor necrosis factor receptor-1 [TNFR-1] and -2 [TNFR-2], plasma soluble urokinase plasminogen activator receptor (suPAR), plasma symmetric dimethylarginine [pSDMA]) ), tubular function (Urine epidermal growth factor [uEGF], Urine asymmetric dimethylarginine [uADMA], Urine symmetric dimethylarginine [uSDMA]), and tubular damage (Urine α-1 microglobulin [α1m], Urine kidney injury molecule-1 [uKIM-1], Urine monocyte chemoattractant protein-1 [uMCP-1]). In CRIC, there were 244 incident end stage kidney disease (ESKD) events, 102 with ≥40% eGFR decline from baseline, and 259 deaths; in REGARDS, there were 121 incident ESKD events and 462 deaths. In CRIC, lower tubular function (hazard ratio per 1-standard deviation, 0.36; 95% confidence interval, 0.25-0.52) and higher tubular damage scores (1.45; 1.18-1.78) were independently associated with higher CKD progression risk. Associations in REGARDS were weaker but directionally consistent (tubular function [0.81; 0.47-1.39] and tubular damage scores [1.12; 0.73-1.72]). Higher tubular damage (1.47; 1.15-1.87) scores were associated with higher mortality risk in CRIC, but not REGARDS ( [1.15; 0.96-1.38]. Higher systemic inflammation and filtration factor scores were associated with higher mortality risk in both cohorts [CRIC: 1.35; 1.07-1.71; REGARDS: 1.41; 1.20-1.65].</p><p><strong>Conclusions: </strong>Three distinct kidney health dimensions were identified, and each associated with CKD progression and/or all-cause mortality in persons with diabetes and CKD.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":""},"PeriodicalIF":8.5000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Journal of the American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2215/CJN.0000000676","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Individual kidney tubule biomarkers are associated with risks for chronic kidney disease (CKD) progression and mortality in persons with diabetes. Integrating multiple kidney biomarkers using a latent variable method of exploratory factor analysis could define distinct dimensions of kidney health, and their associations with adverse outcomes.
Methods: We conducted a factor analysis of 17 candidate urine and plasma biomarkers in 1,256 participants with diabetes and estimated glomerular filtration rate (eGFR) <60ml/min/1.73 m2 from the Chronic Renal Insufficiency Cohort (CRIC; N=701) and the Reasons for Geographic and Racial Differences in Stroke (REGARDS; N=555) studies. We used Cox proportional hazards models to evaluate the associations of identified factors with CKD progression and mortality, adjusting for baseline clinical risk factors, eGFR and albuminuria.
Results: Three factor scores comprising 10 biomarkers were identified: systemic inflammation and filtration (plasma tumor necrosis factor receptor-1 [TNFR-1] and -2 [TNFR-2], plasma soluble urokinase plasminogen activator receptor (suPAR), plasma symmetric dimethylarginine [pSDMA]) ), tubular function (Urine epidermal growth factor [uEGF], Urine asymmetric dimethylarginine [uADMA], Urine symmetric dimethylarginine [uSDMA]), and tubular damage (Urine α-1 microglobulin [α1m], Urine kidney injury molecule-1 [uKIM-1], Urine monocyte chemoattractant protein-1 [uMCP-1]). In CRIC, there were 244 incident end stage kidney disease (ESKD) events, 102 with ≥40% eGFR decline from baseline, and 259 deaths; in REGARDS, there were 121 incident ESKD events and 462 deaths. In CRIC, lower tubular function (hazard ratio per 1-standard deviation, 0.36; 95% confidence interval, 0.25-0.52) and higher tubular damage scores (1.45; 1.18-1.78) were independently associated with higher CKD progression risk. Associations in REGARDS were weaker but directionally consistent (tubular function [0.81; 0.47-1.39] and tubular damage scores [1.12; 0.73-1.72]). Higher tubular damage (1.47; 1.15-1.87) scores were associated with higher mortality risk in CRIC, but not REGARDS ( [1.15; 0.96-1.38]. Higher systemic inflammation and filtration factor scores were associated with higher mortality risk in both cohorts [CRIC: 1.35; 1.07-1.71; REGARDS: 1.41; 1.20-1.65].
Conclusions: Three distinct kidney health dimensions were identified, and each associated with CKD progression and/or all-cause mortality in persons with diabetes and CKD.
期刊介绍:
The Clinical Journal of the American Society of Nephrology strives to establish itself as the foremost authority in communicating and influencing advances in clinical nephrology by (1) swiftly and effectively disseminating pivotal developments in clinical and translational research in nephrology, encompassing innovations in research methods and care delivery; (2) providing context for these advances in relation to future research directions and patient care; and (3) becoming a key voice on issues with potential implications for the clinical practice of nephrology, particularly within the United States. Original manuscript topics cover a range of areas, including Acid/Base and Electrolyte Disorders, Acute Kidney Injury and ICU Nephrology, Chronic Kidney Disease, Clinical Nephrology, Cystic Kidney Disease, Diabetes and the Kidney, Genetics, Geriatric and Palliative Nephrology, Glomerular and Tubulointerstitial Diseases, Hypertension, Maintenance Dialysis, Mineral Metabolism, Nephrolithiasis, and Transplantation.